Lastly, the in vitro findings were substantiated in vivo: the injection of DLBCL cells with METTL3 knockdown resulted in smaller tumors in mice, which was reversed by NEDD1 overexpression. The gene discussed is METTL3; the disease is diffuse large B-cell lymphoma.